Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.46 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5899656 | 0.88 | GPR84 (0.52) | GPR84DNMT1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL9116047 | 0.75 | HSD17B10 (0.44) | GPR84KDM4EALDH1A1HSD17B10HPGD | |
| SCHEMBL12865358 | 0.70 | DNMT1 (0.46) | DNMT1KDM4EALDH1A1HSD17B10HPGD | |
| SCHEMBL289872 | 0.69 | KDM4E (0.64) | GPR84DNMT1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL86321 | 0.67 | CYP19A1 (0.53) | GPR84DNMT1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL12216282 | 0.65 | HTR2A (0.38) | KDM4EALDH1A1HSD17B10HPGDTSHR | |
| SCHEMBL1777121 | 0.65 | GPR84 (0.53) | GPR84DNMT1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL22664856 | 0.65 | GPR84 (0.53) | GPR84DNMT1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL30428179 | 0.65 | GPR84 (0.53) | GPR84DNMT1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL30901145 | 0.65 | GPR84 (0.53) | GPR84DNMT1KDM4EALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7884209-B2 | as redox-dopant and/or emitter in electronic, optoelectronic or electroluminescent structural elements; oxidation and moisture resistance | NOVALED AG (DE) | 2011-02-08 | — | — | US | disclosed |
| US-7884209-B2 | as redox-dopant and/or emitter in electronic, optoelectronic or electroluminescent structural elements; oxidation and moisture resistance | NOVALED AG (DE) | 2011-02-08 | — | — | US | disclosed |
| US-20100234608-A1 | Use of Bora-Tetraazapentalenes | NOVALED AG (DE) | 2010-09-16 | — | — | US | disclosed |
| US-20100234608-A1 | Use of Bora-Tetraazapentalenes | NOVALED AG (DE) | 2010-09-16 | — | — | US | disclosed |
| WO-2007115540-A1 | USE OF BORA-TETRAAZAPENTALENES | NOVALED AG (DE) | 2007-10-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234608-A1 | Use of Bora-Tetraazapentalenes | ETFA, GPX1, CYBB | GPR84 1215/4885DNMT1 2033/4885KDM4E 4724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.